Table 2.

Clinical and Baseline Characteristics of Patients with HCM

	All HCM Patients (n = 114)	Male HCM Patients (n = 83)	Female HCM Patients (n = 31)	P Value
Clinical characteristics
Age, y	52 ± 13	52 ± 14	53 ± 12	0.570
Race				0.749
Chinese	100 (88)	72 (87)	28 (90)
Malay	6 (5)	4 (5)	2 (6)
Indian	8 (7)	7 (8)	1 (3)
Height, m	1.68 ± 0.08	1.71 ± 0.06	1.59 ± 0.06	<0.001
Weight, kg	71 ± 14	75 ± 12	60 ± 13	<0.001
Body surface area, m2	1.80 ± 0.19	1.87 ± 0.15	1.61 ± 0.17	<0.001
Systolic blood pressure, mm Hg	134 ± 20	136 ± 18	128 ± 24	0.044
Diastolic blood pressure, mm Hg	77 ± 12	79 ± 12	73 ± 11	0.018
CMR characteristics
Indexed LV EDV, mL/m2	79 ± 12	80 ± 13	78 ± 10	0.312
Indexed LV ESV, mL/m2	33 ± 9	34 ± 10	32 ± 9	0.419
Indexed LV SV, mL/m2	46 ± 9	46 ± 9	45 ± 8	0.587
Indexed LV mass, g/m2	81 ± 26	85 ± 26	70 ± 21	0.006
LV ejection fraction, %	58 ± 9	58 ± 9	59 ± 9	0.701
Indexed RV EDV, mL/m2	72 ± 16	74 ± 16	66 ± 15	0.016
Indexed RV ESV, mL/m2	27 ± 12	29 ± 12	23 ± 10	0.010
Indexed RV SV, mL/m2	45 ± 9	45 ± 9	43 ± 8	0.310
RV ejection fraction, %	63 ± 10	62 ± 10	67 ± 10	0.025
Global longitudinal strain, %	−11.8 ± 3.1	−11.6 ± 3.3	−12.2 ± 2.5	0.386
Global radial strain, %	29.1 ± 9.4	27.9 ± 8.9	32.4 ± 9.7	0.025
Global circumferential strain, %	−16.9 ± 3.6	−16.5 ± 3.7	−18.0 ± 3.4	0.062
LV mass/EDV	1.03 ± 0.29	1.07 ± 0.30	0.91 ± 0.25	0.009
WTMax, mm	15.0 ± 3.3	15.2 ± 3.4	14.7 ± 3.0	0.484
Indexed WTMax, mm/m2	8.5 ± 2.0	8.2 ± 2.0	9.2 ± 1.8	0.018
Asymmetric ratio	1.97 ± 0.80	1.78 ± 0.61	2.47 ± 1.02	<0.001
Nonischemic fibrosis	87 (76)	61 (73)	26 (84)	0.600
Native T1, ms	1,058 ± 41	1,050 ± 40	1,080 ± 37	0.007
Extracellular volume fraction, %	30.4 ± 4.4	29.5 ± 4.0	32.9 ± 4.7	0.005

Values are mean ± SD or n (%).

HCM = hypertrophic cardiomyopathy; other abbreviations as in Table 1.